A world-class city filled with art and culture and an incredible campus that offers cutting edge resources–that’s what students receive at Penn Nursing. And that’s just the start. Penn Nursing and the wider university offer something for everyone, as well as a lifelong community.

Penn Nursing is globally known for educating dynamic nurses—because our School values evidence-based science and health equity. That’s where our expertise lies, whether in research, practice, community health, or beyond. Everything we do upholds a through-line of innovation, encouraging our exceptional students, alumni, and faculty share their knowledge and skills to reshape health care.

Penn Nursing students are bold and unafraid, ready to embrace any challenge that comes their way. Whether you are exploring a career in nursing or interested in advancing your nursing career, a Penn Nursing education will help you meet your goals and become an innovative leader, prepared to change the face of health and wellness.

Penn Nursing is the #1-ranked nursing school in the world. Its highly-ranked programs help develop highly-skilled leaders in health care who are prepared to work alongside communities to tackle issues of health equity and social justice to improve health and wellness for everyone.

Penn Nursing’s rigorous academic curricula are taught by world renowned experts, ensuring that students at every level receive an exceptional Ivy League education. From augmented reality classrooms and clinical simulations to coursework that includes experiential global travel to clinical placements in top notch facilities, a Penn Nursing education prepares our graduates to lead.

Preventing Diabetes in Philadelphia’s Children (and the World’s)

The study, “25-Hydroxyvitamin D and glycemic control: A cross-sectional study of children and adolescents with type 1 diabetes,” included about 200 children and adolescents from the Diabetes Center for Children at the Children’s Hospital of Philadelphia.

April 20, 2016

During the past two decades, vitamin D status, defined as serum concentration of 25-hydroxyvitamin D, has emerged as a predictor of key clinical outcomes including bone health, glucose metabolism, cardiovascular health, immune health and survival.

Now, a University of Pennsylvania School of Nursing (Penn Nursing) team, including senior author Terri Lipman, PhD, CRNP, FAAN, the Miriam Stirl Endowed Term Professor of Nutrition, Professor of Nursing of Children and Assistant Dean for Community Engagement, has examined the association between 25-hydroxyvitamin D and diabetes control in children and adolescents with type 1 diabetes.

The results demonstrate the high prevalence of patients with low levels of 25-hydroxyvitamin D, specifically in healthy weight and Caucasian children and adolescents with type 1 diabetes— patients previously considered at no or low risk of having low levels of vitamin D. These data underscore the importance of vitamin D screening in all children and adolescents with type 1 diabetes. The team’s findings have been published in Diabetes Research and Clinical Practice.

“To our knowledge this is the first study that has been adequately-powered to examine the association between 25-hydroxyvitamin D and HbA1c (a measure of diabetes control) in children and adolescents with type 1 diabetes,” said Lipman and colleagues.

“These data suggest the need for monitoring of vitamin D in all youth with this disorder.”

The study included about 200 children and adolescents from the Diabetes Center for Children at the Children’s Hospital of Philadelphia, who were recruited during regular follow up visits. Non-fasting blood samples were collected from the participants to measure 25-hydroxyvitamin D and blood glucose levels. HbA1c and other key variables were abstracted from patients’ medical records.

The research team included: Charlene Compher, PhD, RD, LDN, FASPEN, Professor of Nutrition Science; Alexandra L. Hanlon, PhD, Research Professor of Nursing; and was led by Sarah Al Sawah, PhD, a former doctoral student at Penn Nursing and currently a Research Scientist at Eli Lilly and Company. This study was supported, in part, by funding from the Pediatric Endocrinology Nursing Society. Preliminary data from this study were presented at the Annual Conference of the Pediatric Endocrinology Nursing Society Meeting in 2012.

More Stories